Jun 13, 2024, 01:22
Yüksel Ürün: 45 Years of p53
Yüksel Ürün, shared a post by Cancer Cell on X, adding:
“45 Years of p53.
Discovered as a key protein in cancer suppression, p53’s role now spans cell-cycle arrest, apoptosis, metabolism, and immunity.
Activating p53 effectively for cancer therapy remains a challenge.”
Quoting Cancer Cell’s post:
“Understanding the complexity of p53 in a new era of tumor suppression.”
Additional information.
Source: Yüksel Ürün/X and Cancer Cell/X
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes. His dedication to patient care and research inspires positive change in the medical field.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 20, 2024, 17:45
Nov 20, 2024, 17:40
Nov 20, 2024, 17:35
Nov 20, 2024, 17:29
Nov 20, 2024, 17:24
Nov 20, 2024, 16:38
Nov 20, 2024, 16:24